Caprion Pharmaceuticals' Other Investors

Caprion Pharmaceuticals raised a round of funding on , . Investors include EdgeStone Capital Partners.

Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk an…

Articles about Caprion Pharmaceuticals' Other Investors: